CLINICAL_TRIALS
trial_result
· 2019-01-04
Clinical Trial Update: Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques [Phase 2]
Summary
A Phase 2 trial investigating subcutaneous hyaluronidase administration for psoriatic plaques has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tissa Hata, MD | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-04